Home » today » Business » KW 43/2021 | Week with standstill. Is it getting better? Despite Evotec, Steinhoff, Nel, Daimler, Encavis, NIKOLA, Biofrontera, MuM and others reports ()

KW 43/2021 | Week with standstill. Is it getting better? Despite Evotec, Steinhoff, Nel, Daimler, Encavis, NIKOLA, Biofrontera, MuM and others reports ()

Attempt to break out last week, slowed down and back to the beginning at the end. Nothing burned, but also not taken off. While most quarterly reports were initially able to surprise positively or at least the companies were able to live up to their expectations,

After the close of trading on Thursday, the two tech giants Apple and Amazon gave rather sobering numbers. Heavy mortgage for a “year-end rally”. Starbucks also had to pay tribute to China. In Germany it was rather vain: forecast increases, record sales and a pinch of takeover speculation at Qiagen on Friday. So far, supply bottlenecks have had little impact on companies’ quarterly results, but the warnings are getting louder. And what next? Anything is possible: the real estate crisis in China could “land softly”. At least hope is increasing after Evergrande was able to make some interest payments recently. Inflation concerns remain and the associated fear of “too brutal intervention” by the central banks. This contrasts with the previous communication between the most important central bank managers. Who believes in corrections:

“Defensive stocks”. PART 1: DEFAMA, Deutsche Konsum REIT and Noratis. Three real estate stocks that should stay on course even when the stock market turmoil.
“Defensive stocks”. PART 2: Encavis, PNE and BayWa. Three ESG values ​​with continuously growing hidden reserves. Well prepared for more volatile stock market times.

It started last Saturday – as always – with the Weekly review and outlook: KW42 lays the groundwork for year-end rally? Steinhoff, Mutares, NanoRepro, publity, Nel, Encavis,… deliver news.And the revival of the hydrogen values ​​was “underlined” by the IEA:Nel’s optimistic mood through Q3 and the potential order pipeline could be confirmed and accelerated by an IEA study

ADDENDUM 10/30/2021, 9:15 am: EXCLUSIVE INTERVIEW with the CEO of Biofrontera: “… further expand momentum!”. US daughter goes to NASDAQ, but the mother is actually much more exciting.

ADDENDUM October 30, 2021, 11:00 a.m .: Eyemaxx Real Estate AG appoints second board member and still sole board member pledges share package. But what is really important will be back …

ADDENDUM 10/30/2021, 7:00 p.m .: publity’s half-yearly figures show cluster risk and raise questions

Monday

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.